EcoR1 Capital’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19M Buy
+1,904,762
New +$17M 0.81% 16
2025
Q2
Sell
-641,426
Closed -$1.68M 46
2025
Q1
$1.68M Hold
641,426
0.1% 37
2024
Q4
$2.64M Sell
641,426
-1,858,574
-74% -$10.1M 0.11% 48
2024
Q3
$17.7M Buy
+2,500,000
New +$18.7M 0.61% 36
2023
Q4
Sell
-4,163,824
Closed -$35M 56
2023
Q3
$35M Hold
4,163,824
1.19% 17
2023
Q2
$52.3M Hold
4,163,824
1.38% 16
2023
Q1
$68.6M Hold
4,163,824
2.21% 14
2022
Q4
$62.2M Hold
4,163,824
1.89% 14
2022
Q3
$93.1M Buy
4,163,824
+440,283
+12% +$9.66M 2.75% 11
2022
Q2
$62.4M Buy
3,723,541
+1,432,100
+62% +$30.7M 2.17% 14
2022
Q1
$68.6M Buy
2,291,441
+512,357
+29% +$12.4M 2.15% 15
2021
Q4
$54.6M Buy
1,779,084
+393,808
+28% +$12.4M 1.74% 16
2021
Q3
$43.7M Sell
1,385,276
-3,102,500
-69% -$104M 1.54% 15
2021
Q2
$164M Buy
4,487,776
+1,058,413
+31% +$34.9M 6.14% 5
2021
Q1
$119M Buy
3,429,363
+228,714
+7% +$9.93M 5.27% 6
2020
Q4
$133M Hold
3,200,649
7.4% 2
2020
Q3
$136M Buy
+3,200,649
New +$122M 9.84% 3

Other funds holding RLAY